Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

被引:130
作者
Pinzani, Pamela [1 ]
Salvadori, Benedetta
Simi, Lisa
Bianchi, Simonetta
Distante, Vito
Cataliotti, Luigi
Pazzagli, Mario
Orlando, Claudio
机构
[1] Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, I-50100 Florence, Italy
[2] Univ Florence, Dept Human Pathol & Oncol, I-50100 Florence, Italy
[3] Univ Florence, Dept Surg, I-50100 Florence, Italy
关键词
isolation by size of epithelial tumor cells; breast cancer; CK-19 mRNA expression; real-time RT-PCR; laser microdissection; circulating tumor cells;
D O I
10.1016/j.humpath.2006.01.026
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study is the counting and the immunomorphological and molecular characterization of circulating turner cells (CTCs) by the isolation by size of epithelial tumor cells (ISET) method in the peripheral blood of patients with breast cancer. An evaluation of the method's ability to reveal the presence of occult carcinoma cells in blood of a patient with breast cancer was performed and the results compared with those obtained by quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay for the evaluation of cytokeratin-19 (CK-19) mRNA expression. The feasibility of molecular analysis of CTCs after laser microdissection of filters used in ISET was illustrated, referring to HER-2 amplification. Blood samples drawn from 44 patients with breast cancer were preoperatively analyzed by ISET. From the same samples, total RNA was extracted and submitted to quantitative real-time RT-PCR for the detection of CK-19 mRNA-positive cells using TaqMan technology. HER-2 amplification was measured by real-time RT-PCR on DNA extracted from cells recovered by laser microdissection from 7 selected ISET-positive filters. Of 44 samples, 12 (27%) showed the presence of epithelial cells on the filter (mean + SE: 8.5 +/- 2.4 cells per milliliter of blood). A statistically significant agreement (P = .001) was observed between real-time RT-PCR results and those obtained by ISET. With regard to HER-2 amplification, a good correspondence was found between the results obtained from microdissected CTCs and those obtained using DNA extracted from the primary tumor (R = 0.918; P < .01), as well as the immunohistochemistry results. The ISET method allows for the collection of breast carcinoma cells by filtration despite their smaller dimension relative to other carcinoma cell types. The sensitivity and specificity of the method is comparable with those obtained using the quantitative real-time RT-PCR assay for the evaluation of CK-19 mRNA expression. Moreover, the laser microdissection technique allows for the recovery of nucleic acids for further molecular analysis and CTC characterization. (c) 2006 Published by Elsevier Inc.
引用
收藏
页码:711 / 718
页数:8
相关论文
共 24 条
  • [1] Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential
    Anan, K
    Morisaki, T
    Katano, M
    Ikubo, A
    Tsukahara, Y
    Kojima, M
    Uchiyama, A
    Kuroki, S
    Torisu, M
    Tanaka, M
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1998, 24 (01): : 28 - 33
  • [2] The molecular detection of micrometastatic breast cancer
    Baker, M
    Gillanders, WE
    Mikhitarian, K
    Mitas, M
    Cole, DJ
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 186 (04) : 351 - 358
  • [3] BERNS EMJJ, 1992, CANCER RES, V52, P1107
  • [4] Bieche I, 1998, CLIN CANCER RES, V4, P671
  • [5] SENSITIVE DETECTION OF OCCULT BREAST-CANCER BY THE REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION
    DATTA, YH
    ADAMS, PT
    DROBYSKI, WR
    ETHIER, SP
    TERRY, VH
    ROTH, MS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 475 - 482
  • [6] Ding CM, 2004, J BIOCHEM MOL BIOL, V37, P1
  • [7] Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
    Gasparini, G
    Toi, M
    Gion, M
    Verderio, P
    Dittadi, R
    Hanatani, M
    Matsubara, I
    Vinante, O
    Bonoldi, E
    Boracchi, P
    Gatti, C
    Suzuki, H
    Tominaga, T
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 139 - 147
  • [8] Harbeck N, 1998, ANTICANCER RES, V18, P2187
  • [9] Ioachim E, 1996, ANTICANCER RES, V16, P3141
  • [10] Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
    Klein, CA
    Blankenstein, TJF
    Schmidt-Kittler, O
    Petronio, M
    Polzer, B
    Stoecklein, NH
    Riethmüller, G
    [J]. LANCET, 2002, 360 (9334) : 683 - 689